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The	 prevalence	 and	 consequences	 of	malaria	 among	 in-
fants	are	not	well	characterized	and	may	be	underestimat-
ed.	A	better	 understanding	of	 the	 risk	 for	malaria	 in	early	
infancy	 is	 critical	 for	 drug	 development	 and	 informed	 de-
cision	making.	 In	a	cross-sectional	survey	 in	Guinea,	The	
Gambia,	and	Benin,	countries	with	different	malaria	trans-
mission	intensities,	the	overall	prevalence	of	malaria	among	
infants <6	months	of	age	was	11.8%	(Guinea,	21.7%;	The	
Gambia,	3.7%;	and	Benin,	10.2%).	Seroprevalence	ranged	
from	5.7%	in	The	Gambia	to	41.6%	in	Guinea.	Mean	para-
site	densities	in	infants	were	significantly	lower	than	those	
in	children	1–9	years	of	age	in	The	Gambia	(p<0.0001)	and	
Benin	(p	=	0.0021).	Malaria	in	infants	was	significantly	as-
sociated	with	 fever	 or	 recent	 history	 of	 fever	 (p	 =	 0.007)	
and	anemia	(p	=	0.001).	Targeted	preventive	interventions,	
adequate	drug	 formulations,	and	 treatment	guidelines	are	
needed	 to	 address	 the	 sizeable	 prevalence	 of	 malaria	
among	young	infants	in	malaria-endemic	countries.
Infants are thought to be protected against malaria during the first 6 months of life, largely due to the transfer of 
maternal antibodies (1) and the presence of fetal hemoglo-
bin (2). Thus, young infants have received little attention 
in terms of malaria research and treatment guidelines, and 
this age group has systematically been excluded from clini-
cal trials. As a consequence, young infants are frequently 
given off-label antimalarial treatments at dosing sched-
ules recommended for older infants and children (3). The 
lack of attention to case management in this age group is 
a cause of concern and should be addressed, particularly 
when considering the widespread use of artemisinin-based 
combination therapies (ACTs) (4) and ongoing antimalarial 
drug development.
The true prevalence of malaria in young infants is not 
well characterized, yet defining the prevalence is critical, 
especially in light of ongoing epidemiologic shifts in popu-
lations at risk for malaria (5). Data on the prevalence and 
clinical outcomes of malaria in young infants are limited 
and contradictory: some studies show minimal risk (6–8), 
and others report that the risk for malaria increases in the 
first months of life, according to the intensity of transmis-
sion (9). A few reports indicate that the prevalence of dis-
ease is higher than previously thought and that, after birth, 
the period of protection against malaria is shorter than the 
widely quoted 6 months (10,11). However, variations in 
study designs and challenges related to small sample sizes, 
lack of details regarding quality control, and varied pro-
cedures for sample selection make it difficult to interpret 
findings from earlier studies (3). A better understanding of 
the risk for malaria in early infancy is needed to develop 
antimalarial drugs and inform policy decisions for this age 
group (4). To improve our knowledge of malaria in young 
infants, we used standardized methods and more sensitive 
diagnostics to better characterize the prevalence of malaria 
among children <6 months of age in different epidemio-
logic settings.
Methods
Study Population and Sampling Design
This cross-sectional survey was conducted in 3 countries 
in western Africa: The Gambia, Benin, and Guinea (also 
known as Guinea Conakry), representing areas of low, 
Malaria Prevalence among  
Young Infants in Different  
Transmission Settings, Africa
Serign J. Ceesay, Lamine Koivogui, Alain Nahum, Makie Abdoulie Taal, Joseph Okebe, Muna Affara, 
Lama Eugène Kaman, Francis Bohissou, Carine Agbowai, Benoit Gniouma Tolno,  
Alfred Amambua-Ngwa, NFaly Bangoura, Daniel Ahounou, Abdul Khalie Muhammad,  
Stephan Duparc, Kamal Hamed, David Ubben, Kalifa Bojang, Jane Achan, Umberto D’Alessandro
1114	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	21,	No.	7,	July	2015
Author	affiliations:	Medical	Research	Council	Unit,	Fajara,	The	
Gambia	(S.J.	Ceesay,	J.	Okebe,	M.	Affara,	A.	Amambua-Ngwa,	
A.K.	Muhammad,	K.	Bojang,	J.	Achan,	U.	D’Alessandro);	Institut	
National	de	Santé	Publique,	Conakry,	Guinea	(L.	Koivogui,	 
L.E.	Kaman,	B.G.	Tolno);	Centre	de	Recherches	Entomologiques	
de	Cotonou,	Cotonou,	Benin	(A.	Nahum,	F.	Bohissou,	C.	Agbowai,	
D.	Ahounou);	National	Public	Health	Laboratory,	Kotu,	 
The	Gambia	(M.A.	Taal);	Préfectoral	de	la	santé	de	Faranah,	
Guinea	(N.	Bangoura);	Medicines	for	Malaria	Venture,	Geneva,	
Switzerland	(S.	Duparc,	D.	Ubben);	Novartis	Pharmaceuticals	
Corporation,	East	Hanover,	New	Jersey,	USA	(K.	Hamed);	 
London	School	of	Hygiene	and	Tropical	Medicine,	London,	UK	 
(U.	D’Alessandro);	Institute	of	Tropical	Medicine,	Antwerp,	 
Belgium	(U.	D’Alessandro)
DOI:	http://dx.doi.org/10.3201/eid2107.142036
Malaria	among	Young	Infants,	Africa
moderate, and high malaria transmission, respectively. In 
each country, regions were selected to represent overall 
malaria transmission trends and surveys were conducted in 
the catchment areas of 3 health facilities selected by using 
simple random sampling. In The Gambia, the Essau and the 
Soma Major Health Centres and the AFPRC General Hos-
pital in Farafenni were selected out of 6 available sentinel 
surveillance sites. In the southern part of Benin, Bethesda 
Hospital and the Dodji-Bata and Golo-Djigbe health facili-
ties were selected from a total of 12 available facilities, and 
in the Farannah district in Guinea, the Nalia, Tiro, and Ba-
nian health centers were also selected from 12 available 
facilities (Figure 1).
Malaria transmission in The Gambia and Benin is sea-
sonal, occurring during the rainy season, whereas trans-
mission in Guinea occurs year-round. Surveys were timed 
to coincide with the peak of malaria transmission in each 
country: October–November 2011 in The Gambia and 
Guinea; July–August 2012 in Benin. Before conducting the 
surveys, we explained the study objectives to community 
members in the catchment areas and obtained community 
approval. We identified households with infants by review-
ing delivery records to detect births in the 6 months before 
the survey; traditional birth attendants assisted with the re-
views. An information sheet explaining the objectives of 
the survey and the study procedures was then distributed to 
the parents of the infants. After written informed consent 
was obtained from parents, identified infants were enrolled 
in the study. In households with >2 eligible infants, 1 in-
fant was selected by using simple random sampling. Once 
the index infant was selected, 2 older children (1–9 and 
10–15 years of age) living in the same household were also 
selected by simple random sampling and included in the 
study with the objective of estimating the force of transmis-
sion and differences in the local risk for infection between 
infants and older children. If children of the required age 
group were not available within the infant’s household, the 
nearest households were visited consecutively until eligible 
children were identified and enrolled.
Data Collection
Study participants underwent a physical examination; axil-
lary temperature and weight were recorded for each child. 
Information on the use of bed nets, including long-lasting 
insecticidal nets, and history of fever in the previous 24 
hours was collected by using a structured questionnaire. All 
study participants had a blood sample collected by finger 
prick (children 1–15 years of age) or heel prick (infants 
<6 months of age). A rapid malaria diagnostic test (RDT) 
(ICT Malaria P.f. Cassette Test [ML01]; ICT Diagnostics, 
Cape Town, South Africa) was performed, and children 
who tested positive were immediately treated according to 
treatment guidelines for the country in which they lived. 
Hemoglobin concentration was measured by using a He-
moCue Hb 301 System (HemoCue AB, Ängelholm, Swe-
den) according to the manufacturer’s instructions. Thick-
film blood slides were stained with 10% Giemsa for 10 
min, and the presence of Plasmodium falciparum parasites 
was determined by reading 100 high-power fields under oil 
immersion. Slides were read independently by 2 microsco-
pists, and parasite density was estimated by counting the 
numbers of asexual parasites per 200 leukocytes. Results 
were expressed as the number of parasites per microliter, 
assuming a total leukocyte count of 8,000 cells/μL. A 20% 
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Figure 1.	Study	sites	(arrows)	
in	a	study	of	malaria	prevalence	
among	young	infants	in	The	
Gambia,	Benin,	and	Guinea.	
Inset	shows	locations	of	the	3	
countries	in	western	Africa.
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error check was used to identify discrepancies between 
slide readers. All discordant results were read by a senior 
microscopist, and the result was used as the final read. 
Blood slides from Guinea and The Gambia were read at 
the Medical Research Council (MRC) Unit in The Gambia; 
blood slides from Benin were read, following the same pro-
tocol, at Entomological Research Centre of Cotonou. The 
first 99 slides from Benin were read again in The Gambia; 
results were comparable.
Molecular diagnosis of malaria parasites and specia-
tion of Plasmodium species were conducted by using dry 
blood-spot samples (DBSs) collected on filter paper (What-
man 3MM; Whatman 3 Corporation, Florham Park, NJ, 
USA). DNA was extracted from 3 disks (6-mm diameter), 
which had been punched from DBSs by using a QIA X-
tractor robot (QIAGEN, Venlo, Limburg, Netherlands) 
according to the manufacturer’s protocol, and analyzed by 
using nested PCR as previously described (12).
To determine the prevalence of malaria antibodies, 
we punched disks (6-mm diameter) from DBSs and placed 
them in 96-well plates. Serum that had been eluted after 
overnight (18 h) incubation at room temperature in 150 
μL of reconstitution buffer (150 μL phosphate-buffered 
saline/0.05% [vol/vol] Tween 20/0.05% [wt/vol] sodium 
azide) was used to determine antibodies against the 19-kDa 
merozoite surface protein 1 (MSP119) by indirect ELISA, 
as previously described (13,14). MSP119 used in these as-
says was obtained from the London School of Hygiene and 
Tropical Medicine (London, UK).
Sample Size and Statistical Analysis
The sample size was computed on the lowest expected 
prevalence of infection, assumed to be 2% in The Gam-
bia. For each country, we estimated that 750 children in 
each of the 3 age categories would be sufficient to de-
termine the prevalence of malaria. Assuming infants <6 
months of age made up ≈2%–3% of the total population, 
the required sample size would be found within a popula-
tion of ≈40,000 persons.
 Data from the case record forms were double- 
entered into an OpenClinica database (https://community. 
openclinica.com/). After being cleaned, the data were 
analyzed by using Stata Statistical Software, release 12.1 
(StataCorp LP, College Station, TX, USA). Baseline data 
were analyzed by descriptive methods, and summary statis-
tics were presented as means ±SDs for continuous data and 
frequencies and proportions for categorical data. The χ2 test 
was used to analyze differences in proportions. Two-tailed 
p values and a 5% significance level were used. Results for 
infants <6 months of age from all 3 countries were pooled 
together, and univariate and multivariate logistic regression 
analyses were performed to determine features associated 
with malaria in this age group. A forward fitting logistic 
regression model was used to account for confounders 
and interaction. The odds for malaria with increasing age 
within the 0- to 6-month-old age group was determined and 
presented by country.
For the serologic tests, the distributions of log-trans-
formed antibody titers were fitted as the sum of 2 Gaussian 
distributions, which were assumed to represent a narrower 
distribution of seronegative results to the left and a broader 
distribution of seropositive results to the right. The mean 
concentration of the seronegative distribution (the distribu-
tion with the smallest mean) +2 SDs was considered the 
seropositivity cutoff (15).
Ethical Considerations
The study was approved by The Gambia Government/MRC 
Joint Ethics Committee, National Committee of Ethics for 
Health Research (Benin), and the National Committee of 
Ethics for Health Research (Guinea). Written informed 
consent was obtained from the parents of each participant 
by a signature or thumbprint.
Results
Characteristics of the Study Population
A total of 6,761 children were included in the survey: 
2,270 from The Gambia, 2,276 from Benin, and 2,215 
from Guinea. The number of children categorized by age 
group, sex, and mean weight by age was comparable be-
tween countries (Table 1). Almost 40% (838/2,219) of 
the infants weighed <5 kg; no difference in weight was 
seen by country. In The Gambia and Benin, bed net cov-
erage (defined as having slept under a bed net the night 
before the survey) was >90% in children 0–6 months and 
1–9 years of age (Table 1). Conversely, bed net cover-
age was extremely low across all age groups in Guinea; 
only ≈30% of children <10 years of age and 14% of chil-
dren 10–15 years age used bed nets (Table 1). Overall, 
the prevalence of fever was lower among children 10–15 
years than among infants 0–6 months of age. The high-
est percentage of fevers (48.1%, 359/747] and the lowest 
mean hemoglobin level (10.0 g/dL [SD 1.7]) were among 
1- to 9-year-old children in Guinea.
Prevalence of Malaria
By all 3 diagnostic methods, malaria prevalence was lowest 
in The Gambia and highest in Guinea; Benin had interme-
diate values. In all 3 countries, malaria prevalence was gen-
erally lower in infants 0–6 months of age (Table 2). Results 
from the RDT and microscopy were comparable, although, 
with 1 exception, the RDT tended to identify more posi-
tive samples. The exception was that microscopy showed a 
much higher prevalence of malaria among young infants in 
The Gambia (Table 2).
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By microscopy, all malaria cases identified in children 
from The Gambia were determined to be caused by infection 
with P. falciparum parasites. In Benin and Guinea, P. ma-
lariae and P. ovale parasite infections were also identified, 
predominantly as mixed infections. In Guinea, the preva-
lence of P. malariae parasite infections was 0.3% (2/724) 
in young infants, 12.0% (90/748) in children 1–9 years of 
age, and 5.8% (43/743) in children 10–15 years of age. Of 
these infections, 97% (131/135) were mixed infections with 
P. falciparum parasites. The prevalence of P. ovale parasite 
infection in Guinea was 3.1% (23/748) in children 1–9 
years of age and 0.9% (7/743) in children 10–15 years of 
age; no cases were detected among young infants. In Be-
nin, the prevalence of P. malariae parasite infection was 
0.1% (1/761) in young infants, 1.7% (13/759) in children 
1–9 years of age, and 2.8% (21/756) in children 10–15 years 
of age. In Benin, 34% (12/35) of the infections were mixed 
P. malariae and P. falciparum parasite infections. Overall, 
the mean parasite density per microliter of blood was 371.5 
in The Gambia, 1,688.3 in Benin, and 2,037.9 in Guinea.
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Table 1. Characteristics	of	children	in	a	study	of	malaria	prevalence	among	young	infants	in	different	transmission	settings,	Africa 
Characteristic The	Gambia,	N	=	2,270 Benin,	N	=	2,276 Guinea,	N	=	2,215 
Age	groups,	no.	(%)    
 0–6	mo 734	(32.3) 761	(33.4) 724	(32.7) 
 1–9	y 768	(33.8) 759	(33.3) 748	(33.8) 
 10–15	y 768	(33.8) 756	(33.2) 743	(33.5) 
Sex,	no.	(%)    
 F 1,222	(53.8) 1,189	(52.2) 1,159	(52.3) 
 M 1048	(46.2) 1087	(47.8) 1056	(47.7) 
Mean	weight,	kg	(SD)    
 0–6	mo 5.8	(3.6) 5.2	(1.5) 5.5	(2.5) 
 1–9	y 12.8	(3.6) 14.3	(4.1) 14.4	(4.1) 
 10–15	y 31.2	(7.5) 30.1	(7.8) 31.6	(7.6) 
Bed	net	coverage,	no./no.	total	(%)*    
 0–6	mo 699/727	(96.1) 678/750	(90.4) 225/723	(31.1) 
 1–9	y 724/765	(94.6) 656/722	(90.9) 222/746	(29.8) 
 10–15	y 642/752	(85.4) 581/727	(79.9) 103/740	(13.9) 
Fever or history of fever, no./no. total (%)†    
 0–6	mo 136/732	(18.6) 129/758	(17.0) 282/724	(38.9) 
 1–9	y 133/768	(17.3) 119/758	(15.7) 359/747	(48.1) 
 10–15	y 56/760	(7.4) 83/756	(11.0) 221/743(29.7) 
Mean	hemoglobin	level,	g/dL	(SD)    
 0–6	mo 11.8	(2.2) 11.3	(2.0) 12.1	(3.7) 
 1–9	y 10.9	(1.5) 11.2	(1.4) 10.0	(1.7) 
 10–15	y 12.4	(1.4) 12.3	(1.6) 11.8	(1.4) 
*Defined	as	having	slept	under	a	bed	net	the	night	before	survey. 
†History of fever refers to fever in the 24 h before the structured questionnaire was completed. 
 
 
 
 
Table 2. Prevalence	of	Plasmodium species	parasites,	by	testing	method,	among	children	in	different	transmission	settings,	Africa 
Test	method,	age	group 
No./no.	total	(%) 
The	Gambia,	N	=	2,270 Benin,	N	=	2,276 Guinea,	N	=	2,215 
Rapid	malaria	diagnostic	test*    
 0–6	mo 3/734	(0.4) 23/761	(3.0) 161/724	(22.2) 
 1–9	y 11/768	(1.4) 254/759	(33.5) 667/748	(89.2) 
 10–15	y 35/768	(4.6) 317/756	(41.9) 611/743	(82.2) 
Microscopy    
 P. falciparum    
  0–6	mo 25/734	(3.4) 25/761	(3.3) 133/724	(18.4) 
  1–9	y 8/768	(1.0) 201/759	(26.5) 574/748	(76.7) 
  10–15	y 21/768	(2.7) 284/756	(37.6) 612/743	(82.4) 
 P. falciparum gametocytes    
  0–6	mo 1/734	(0.1) 7/761	(0.9) 61/724	(8.4) 
  1–9	y 2/768	(0.3) 66/759	(8.7) 138/748	(18.4) 
  10–15	y 7/768	(0.9) 70/756	(9.3) 91/743	(12.2) 
PCR    
 Plasmodium spp.    
  0–6	mo 27/734	(3.7) 78/761	(10.2) 157/724	(21.7) 
  1–9	y 18/768	(2.3) 243/759	(32.0) 591/748	(79.0) 
  10–15	y 35/768	(4.6) 324/756	(42.9) 577/743	(77.7) 
 P. falciparum    
  0–6	mo 9/734	(1.2) 41/761	(5.4) 139/724	(19.2) 
  1–9	y 10/768	(1.3) 193/759	(25.4) 531/748	(71.0) 
  10–15	y 25/768	(3.3) 234/756	(30.9) 502/743	(67.6) 
*ICT	Malaria	P.f.	Cassette	Test	(ML01)	(ICT	Diagnostics,	Cape	Town,	South	Africa). 
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For the 3 countries, Plasmodium spp.–specific PCR 
also showed a higher prevalence of malaria in all age 
groups with increasing malaria transmission intensity 
(Table 2). Prevalence of malaria in infants, as determined 
by molecular methods, was higher in Guinea (21.7%, 95% 
CI 18.7%–24.7%) than in Benin (10.2%, 95% CI 8.1%–
12.4%) and The Gambia (3.7%, 95% CI 2.3%–5.0%) 
(Table 2). Species-specific PCR results, compared with 
microscopy results, showed a lower prevalence of P. falci-
parum parasite infection in children >10 years of age in Be-
nin (30.9% [234/756] vs. 37.6% [284/756]; p = 0.006) and 
Guinea (67.6% [502/743] vs. 82.4% [612/743]; p<0.0001) 
(Table 2). However, in The Gambia, species-specific PCR 
results, compared with microscopy results, showed a lower 
prevalence of P. falciparum infection only in young infants 
(1.2% [9/734] vs. 3.4% [25/734]; p = 0.005). Gametocyte 
prevalence by microscopy was lower in infants and in-
creased with age and transmission intensity across the 3 
countries (Table 2).
Prevalence of Malaria Antibodies
Overall, the prevalence of MSP119 antibodies varied from 
5.7% among young infants in The Gambia to 45.9% among 
1- to 9-year-old children in Guinea (Table 3). Antibody se-
roprevalence generally increased with age and with trans-
mission intensity across the 3 countries. With the exception 
of results for children >1 year of age in Guinea, antibody 
seroprevalence was higher than the prevalence of infection 
as determined by microscopy (Table 3). For young infants, 
antibody seroprevalence was also higher than parasite prev-
alence and increased with transmission intensity from 5.7% 
in the Gambia to 36.5% in Benin and 41.6% in Guinea.
Malaria in Infants 0–6 Months of Age
The overall prevalence of malaria among infants was 
8.2% (183/2,219) as determined by microscopy and 
11.8% (262/2,219) as determined by PCR; the prevalence 
was substantially higher in Guinea than in Benin or The 
Gambia (Table 2). Mean parasite densities per milliliter 
of blood were significantly lower in infants than in 1- to 
9-year-old children in The Gambia (68/μL [SD 168] vs. 
26,708/µL [SD 32,074]; p<0.0001]) and in Benin (6,894/
µL [SD 20,567] vs. 12,933/µL [SD 49,895]; p = 0.0021) 
but not in Guinea (5,725/µL [SD 11,423] vs. 5,479/µL 
[SD 21,689]; p = 0.89).
Malaria in infants was significantly associated with fe-
ver or history of fever in the previous 24 hours (adjusted 
odds ratio [aOR] 1.65, 95% CI 1.15–2.37; p = 0.007), axil-
lary temperature >37.5°C (aOR 2.07, 95% CI 1.08–3.98; 
p = 0.029), and anemia (aOR 5.54, 95% CI 3.91–7.84; p = 
0.001) (Table 4). Infants weighing <5 kg had significantly 
higher odds for having malaria (aOR 3.45, 95% CI 2.22–
5.26, p = 0.001).
In The Gambia and Benin, the odds for having malaria 
remained almost stable across the 0- to 6-month-old age 
group (Figure 2). In contrast, lower odds for having malaria 
was seen in infants 0–2 months of age in Guinea and mark-
edly increasing odds for having malaria was seen in infants 
2–6 months of age. The overall trend was lower odds for 
malaria in infants 0–3 months of age and subsequently in-
creasing odds for malaria from ≈3 to 6 months of age (Fig-
ure 2). In Guinea and Benin, antibody titers were higher 
early in infancy, declined steadily over the 0- to 4-month 
age range, and then increased slightly after 4 months of 
age. Conversely, in The Gambia, infants had lower anti-
body titers and little evidence of increasing titers over the 
0- to 6-month age range (Figure 3).
Discussion
The prevalence of malaria among infants 0- to 6-months 
of age was not trivial (range 3.7%–22%, by PCR) and in-
creased with transmission intensity, as documented by the 
prevalence among older children. This variability in preva-
lence may be due to differences in transmission intensity 
but may also be due to differences in the use of preven-
tive measures, as illustrated by the extremely low use of 
bed nets in Guinea. Such low intervention coverage may be 
an indicator of weak health systems with limited access to 
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Table 3. Anti–MSP119 antibody	seropositivity	and	Plasmodium falciparum parasite	prevalence	among	children	in	different	transmission	
settings,	Africa* 
Country,	age	group Parasite	prevalence, no. (%)† Antibody	seropositive,	no.	(%) p	value 
The	Gambia,	N	=	2,270    
 0–6	mo 25	(3.4) 33	(5.7) 0.044 
 1–9	y 8	(1.0) 53	(7.0) <0.001 
 10–15	y 21	(2.7) 57	(8.1) <0.001 
Benin,	N	=	2,276    
 0–6	mo 25	(3.3) 269	(36.5) <0.001 
 1–9	y 201	(26.5) 303	(41.5) <0.001 
 10–15	y 284	(37.6) 311	(42.5) 0.054 
Guinea,	N	=	2,215    
 0–6	mo 133	(18.4) 299	(41.6) <0.001 
 1–9	y 574	(76.7) 339	(45.9) <0.001 
 10–15	y 612	(82.4) 320	(44.2) <0.001 
*MSP119,	19-kDa	merozoite	surface	protein. 
†Prevalence as	determined	by	microscopy. 
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other malaria control interventions (e.g., prompt and effica-
cious treatment and intermittent preventive treatment for 
pregnant women), which enable an efficient cycle of ma-
laria transmission in local populations, including infants.
In the low-transmission setting in The Gambia, the 
risk for malaria did not vary substantially between age 
groups. This finding was in obvious contrast to those in 
Benin and Guinea, where prevalence among infants was 
substantially lower than that among older children. This 
suggests that in areas where transmission has decreased 
substantially to low levels, the risk for infection may be 
shared by the entire population, including infants, and in 
high-transmission settings, infection in infants may be 
relatively limited by passively transferred maternal anti-
bodies or possibly by lower attractiveness of infants to 
mosquitoes (16,17). The prevalence figures reported are 
consistent with those of earlier studies, which were lim-
ited by smaller sample sizes, different selection criteria, 
and small geographic areas (4,6,11,18–20). The results of 
our surveys in these 3 countries in western Africa provide 
a regional estimate of the current prevalence of malaria 
among infants. The survey was conducted by using a rela-
tively large sample size and robust methods of malaria 
diagnosis, factors that enhance the generalizability of the 
findings to other settings.
It is not surprising that MSP119 antibody seropreva-
lence was generally higher than parasite prevalence in 
young infants: this finding may be a reflection of maternal 
antibodies passively transferred to the fetus during the last 
trimester of pregnancy (21) and not necessarily a reflection 
of the infant’s own responses. Prenatal transfer of antibod-
ies may also explain the dynamics of MSP119 antibody ti-
ters in young infants. In Guinea and Benin, high titers were 
observed in children in early in infancy, followed by a 
rapid decline in mean antibody titers until 4 months of age 
and then a subsequent slight increase. In contrast, infants in 
The Gambia had lower antibody titers and little evidence of 
an increase over the 0- to 6-month age range, indicating no 
substantial ongoing endogenous antibody production.
P. falciparum was the dominant parasite species in all 
age groups, but a few cases of P. malariae and P. ovale 
infection (mostly mixed infections with P. falciparum 
parasites) were found among infants in Guinea and Benin. 
Therefore, currently available ACTs should suffice for the 
management of these cases, although failed parasite clear-
ance has been reported in some P. malariae and P. ovale 
parasite–infected persons treated with ACTs (22).
Malaria in infants was significantly associated with 
fever or with a history of fever in the 24 hours before the 
survey, but only 10% of infants with malaria had an axillary 
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Table 4. Characteristics	of	0- to	6-month-old	infants	with	malaria	in	3	African	countries	with	different	transmission	settings 
Variable 
No	malaria,	n	(%),	
N	=	2,036 
Malaria,	n	(%),	
N	=	183 
Odds ratio	(95%	CI) 
p	value Crude Adjusted* 
Country      
 The	Gambia 709	(96.6) 25	(3.4) Reference Reference  
 Benin 736	(96.7) 25	(3.3) 0.96	(0.55–1.69) 0.74	(0.41–1.32) 0.307 
 Guinea 591	(81.6) 133	(18.4) 6.38	(4.11–9.92) 5.28	(3.30–8.44) 0.001 
Sex      
 F 1,040	(92.8) 81	(7.2)    
 M 996	(90.7) 102	(9.3) 1.31	(0.97-1.78) 1.13	(0.80–1.59) 0.491 
Fever or history of fever†      
 No 1,573	(94.4) 94	(5.6)    
 Yes 458	(83.7) 89	(16.3) 3.25	(2.38–4.44) 1.65	(1.15–2.37) 0.007 
Anemia‡      
 No 1,724	(95.5) 81	(4.5)    
 Yes 312	(75.4) 102	(24.6) 6.96	(5.01–9.67) 5.54	(3.91–7.84) 0.001 
Weight,	kg      
 <5 1,225	(88.7) 156	(11.3)    
 >5 811	(96.8) 27	(3.2) 0.26	(0.17–0.40) 0.29	(0.19–0.45) 0.001 
*Adjusted	for	country,	sex,	fever,	anemia,	age,	and	weight. 
†History of fever refers to fever in the 24 h before the structured questionnaire was completed. 
‡Defined as hemoglobin level of <10 g/dL. 
 
Figure 2.	Odds	of	having	
malaria,	with	increasing	age,	
in	infants	0–6	months	of	age	
in	Benin	and	The	Gambia	
(A),	Guinea	(B),	and	in	the	3	
countries	overall	(C).	Note	that	
the	scale	of	the	y-axis	in	panel	
B	differs	from	that	in	panels	A	
and	C.
RESEARCH
temperature >37.5°C at the time of the survey. Although 
parasite densities in infants were lower than those in old-
er children, about half of the infants with malaria were 
symptomatic. This finding contrasts with the long-held 
belief that malaria in young infants is not associated with 
clinical symptoms (23,24). The findings from this survey 
therefore provide evidence that malaria in young infants 
may be symptomatic and should be evaluated for and 
treated. In addition, malaria in this age group was signifi-
cantly associated with anemia, indicating that malaria can 
have a major negative effect on the health of infants. Oth-
er previously reported clinical manifestations (e.g., sple-
nomegaly, hepatomegaly, jaundice, vomiting, diarrhea, 
poor feeding, restlessness, drowsiness, pallor, respiratory 
distress, and convulsions) (25,26) were not consistently 
documented in this survey. A study systematically inves-
tigating for malaria in all 0- to 6-month-old infants attend-
ing health facilities in the same areas as this survey has 
recently been completed and should provide more infor-
mation on the clinical signs and symptoms of malaria in 
this age group; that study used RDTs, microscopy, PCR, 
and hemoglobin measurements.
We have shown that malaria in young infants is not rare, 
can be symptomatic, and has major health consequences, 
most notably anemia. Current World Health Organization 
guidelines recommend the use of ACTs in infants, but they 
specify that for young infants weighing <5 kg, the avail-
able evidence is insufficient to confidently recommend this 
treatment. Thus, many of the ACTs carry label restrictions 
saying they should not be used for infants weighing <5 kg 
(27). This restriction is problematic because a substantial 
proportion (40%) of the infants in these surveys weighed 
<5 kg and would therefore not meet standard criteria for 
treatment with ACTs. In addition, there are few pediatric 
ACT formulations, and the dosing is often difficult. There-
fore, data on the efficacy and safety of ACTs in young in-
fants is urgently needed to inform optimal treatment.
The tools used in our study provided comparable esti-
mates of the prevalence of malaria in young infants, with 
the exception of RDTs, which greatly underestimated the 
prevalence of malaria in The Gambia, possibly because 
of the low parasite densities (28,29). Prevalence estimates 
determined by microscopy and PCR were surprisingly 
similar, which may be due to the high sensitivity of mi-
croscopy readings conducted in a research institution with 
strict quality-control procedures. Using microscopy, we 
were able to detect parasite densities as low as 2 parasites/
µL of blood; it is estimated, however, that in an average 
health care facility with standard microscopy, the detection 
threshold would be 50–100 parasites/µL of blood (30,31). 
In some sites, the lower prevalence by PCR, compared with 
RDT, may be due to persistent antigenemia from past in-
fections in the absence of current parasitemia.
The overall dynamics of infection across the 3 coun-
tries suggests that the period of protection against ma-
laria may be the first 3 months of life, and thereafter the 
odds for malaria rise increasingly by age. Our findings 
therefore provide evidence that the period of perinatal 
protection may be shorter than 6 months and that the 0- 
to 6-month-old age group is not a homogenous group in 
terms of malaria susceptibility. Thus, the challenge is that 
young infants are not adequately protected against malar-
ia because of their limited coverage by current preventive 
strategies, such as seasonal malaria chemoprevention and 
intermittent preventive treatment during infancy, which 
are not widely implemented. This inadequate coverage is 
critical because our findings show that young infants can 
be affected by malaria and subsequently become anemic, 
which would also potentially increase their vulnerability 
to other pathogens (32). Other interventions, such as the 
RTS,S/AS01 malaria vaccine, which will soon be regis-
tered for use, resulted in modest protection against clini-
cal malaria in this age group and did not have any effect 
on preventing anemia (33).
In conclusion, the prevalence of malaria is sizeable 
among young infants living in malaria-endemic countries. 
This problem must be addressed through the development 
of adequate pediatric drug formulations, targeted preventive 
interventions, and treatment guidelines for young infants.
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